TARGETTI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.016
EU - Europa 1.605
AS - Asia 1.547
SA - Sud America 215
AF - Africa 43
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.960
RU - Federazione Russa 533
SG - Singapore 444
CN - Cina 421
IT - Italia 399
PL - Polonia 195
HK - Hong Kong 186
BR - Brasile 174
VN - Vietnam 162
KR - Corea 130
IE - Irlanda 96
SE - Svezia 95
DE - Germania 67
IN - India 53
FR - Francia 52
BD - Bangladesh 50
FI - Finlandia 46
GB - Regno Unito 34
CA - Canada 31
JO - Giordania 26
NL - Olanda 24
AR - Argentina 21
ID - Indonesia 18
JP - Giappone 17
AU - Australia 15
MX - Messico 15
CH - Svizzera 10
UA - Ucraina 10
ES - Italia 9
MA - Marocco 9
DK - Danimarca 8
IQ - Iraq 7
PK - Pakistan 7
ZA - Sudafrica 7
BJ - Benin 6
NG - Nigeria 6
RO - Romania 6
BE - Belgio 5
CL - Cile 4
DO - Repubblica Dominicana 4
EC - Ecuador 4
TR - Turchia 4
CO - Colombia 3
LT - Lituania 3
MY - Malesia 3
PE - Perù 3
PH - Filippine 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AO - Angola 2
AT - Austria 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HN - Honduras 2
KE - Kenya 2
LK - Sri Lanka 2
PT - Portogallo 2
PY - Paraguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
SC - Seychelles 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.443
Salva come PNG Salva come JPEG
Città #
Santa Clara 399
Singapore 360
Ashburn 307
Warsaw 185
Hong Kong 164
Hefei 137
Seoul 128
San Jose 123
Dublin 96
Dallas 89
Fairfield 86
Chandler 63
Beijing 58
Ho Chi Minh City 54
Milan 54
Seattle 47
Munich 43
Ann Arbor 39
Florence 39
Houston 37
New York 34
Woodbridge 34
Wilmington 33
Los Angeles 31
Cambridge 30
Mumbai 30
Rome 30
Lawrence 29
Altamura 28
Council Bluffs 28
Buffalo 27
Hanoi 26
The Dalles 26
Lauterbourg 24
São Paulo 23
Shanghai 20
Turku 20
Boston 19
Princeton 18
Moscow 17
Scandicci 17
Frankfurt am Main 15
Helsinki 15
Melbourne 15
Tokyo 15
Kent 14
Amersfoort 13
Boardman 13
Chicago 11
Jakarta 11
Philadelphia 11
Brooklyn 10
Bologna 9
Lappeenranta 9
Bengaluru 8
Montreal 8
Naples 8
Siena 8
Toronto 8
Bern 7
Biên Hòa 7
Brasília 7
Copenhagen 7
Da Nang 7
London 7
Andover 6
Atlanta 6
Cotonou 6
Fontebuona 6
Medford 6
Phoenix 6
Tianjin 6
Abuja 5
Changsha 5
Figino 5
Hải Dương 5
Mexico City 5
Orem 5
Padua 5
Paris 5
Rio de Janeiro 5
San Diego 5
Turin 5
Avellino 4
Barcelona 4
Barnet 4
Brescia 4
Brussels 4
Cagliari 4
Casablanca 4
Curitiba 4
Dearborn 4
Dong Ket 4
Miano 4
Salerno 4
Santo Domingo 4
Stockholm 4
Vancouver 4
Wroclaw 4
Yubileyny 4
Totale 3.460
Salva come PNG Salva come JPEG
Nome #
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 484
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 220
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 214
Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria 202
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 198
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 196
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 191
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy 187
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 186
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 181
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 179
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 176
Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration 172
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 168
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 167
[From loss to prevention: lessons to be learned from juvenile sudden death] 159
Genetic basis of pediatric sarcomeric hypertrophic cardiomyopathy: impact on long term outcome 157
P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes 154
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 154
Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy 152
The Diagnostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy: Novel ECG Signs 151
Diagnostic Delay in Arrhythmogenic Cardiomyopathy 149
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy 149
Cellular Retrograde Cardiomyoplasty and Relaxin Therapyfor Postischemic Myocardial Repair in a Rat Model 143
Genotype-Negative Patients With Familial Hypertrophic Cardiomyopathy 139
Clinical features and outcomes in carriers of pathogenic desmoplakin variants 139
Aficamten and Cardiopulmonary Exercise Test Performance 136
Comparative analysis of a 4-lead portable smartphone-based versus standard 12-lead electrocardiograph for cardiovascular screening in low-income settings 131
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 127
Cardiopulmonary Fitness and Personalized Exercise Prescription in Patients With Hypertrophic Cardiomyopathy 106
Arrhythmic risk stratification in patients with left ventricular ring-like scar 106
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants 44
Long-Term Follow-Up Data on Flecainide Use as an Antiarrhythmic in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multicenter Study 41
The Diagnostic and Prognostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy 16
Evolving Epidemiology of Cardiomyopathies at a National Referral Centre: a 30-Year Longitudinal Study 9
Myocardial performance during exercise in hypertrophic cardiomyopathy; pressure volume loops and haemodynamic forces analysis 7
Totale 5.490
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022134 4 9 7 8 4 6 8 10 6 11 23 38
2022/2023444 30 105 26 9 23 61 61 29 50 8 31 11
2023/2024245 5 20 31 16 25 44 18 43 8 7 12 16
2024/20251.533 56 142 111 205 342 188 38 129 46 42 104 130
2025/20262.564 275 373 330 253 232 83 270 101 198 144 91 214
Totale 5.490